Head-to-head · WeighScore
Boston Medical Group vs Remote Pharmacy
The verdict
Remote Pharmacy takes it — 69.9/100 to 61.9/100.
Remote Pharmacy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Boston Medical Group | Remote Pharmacy |
|---|---|---|
| WeighScore | 61.9/100 | 69.9/100 |
| Grade | C | C |
| Scorecard rank | #279 | #110 |
| Semaglutide | $199/mo (starting strength, rising with dose, compounded) | $167/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $230/mo (all doses, compounded) |
| Coverage | 7 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #279 · C
Strengths
- An established medical group with a defined 12-week programme rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
Where it loses points
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
- The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
- Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #110 · C
Strengths
- Low cash-pay pricing with no subscription or hidden fees
- Free doctor consultation and free shipping (you pay only for medication)
- Offers injectable and sublingual or tablet forms of both drugs
- Medication made by 503A-certified compounding facilities
Where it loses points
- Does not publicly name its specific compounding pharmacies or clinical provider
- Covered states are not listed on the pages reviewed
- Newer brand with limited third-party track record
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.